Melatonin's Effect in Febrile Seizures and Epilepsy

Abolfazl Mahyar1, Parviz Ayazi1, Reza Dalirani2

  • 1Department of Pediatrics, Qazvin University of Medical Sciences, Qazvin, Iran.

Insights

Serum melatonin levels show no association with febrile seizures (FS) or epilepsy in children. This study indicates melatonin does not play a significant role in these common childhood convulsive disorders.

Area of Science:

  • Pediatric Neurology
  • Endocrinology
  • Convulsive Disorders

Background:

  • Febrile seizures (FS) and epilepsy are common neurological conditions in children.
  • Understanding risk factors for these disorders is crucial for effective management.
  • The potential role of melatonin in convulsive disorders requires further investigation.

Purpose of the Study:

  • To investigate the relationship between serum melatonin levels and febrile seizures (FS) in children.
  • To determine if melatonin levels differ in children with epilepsy compared to controls.
  • To assess the potential role of melatonin in the pathophysiology of FS and epilepsy.

Main Methods:

  • A comparative study involving 111 children diagnosed with simple FS, complex FS, or epilepsy.
  • A control group of 37 febrile children without seizures was included.
  • Serum melatonin levels were quantified and compared across all study groups.

Main Results:

  • Serum melatonin levels were comparable across groups: simple FS (2 pg/ml), complex FS (2.4 pg/ml), epilepsy (2 pg/ml), and controls (2.1 pg/ml).
  • No statistically significant differences in serum melatonin levels were found between children with FS or epilepsy and the control group.
  • Analysis revealed no significant variations when comparing the different case groups.

Conclusions:

  • The study found no association between serum melatonin levels and the occurrence of simple or complex febrile seizures.
  • Serum melatonin levels did not show a significant correlation with epilepsy in the pediatric population.
  • Current evidence suggests melatonin does not play a significant role in the development or progression of these convulsive disorders.
Abstract

Related Concept Videos

Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
956
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
30
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.3K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K